Mineralys Therapeutics, Inc.
Total Trades
66
Buys
16
Sells
34
Largest Trade
$1M+
Insiders
10
Institutional Funds
167
Inst. Value
$1M+
Activist Filings
22
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Rodman David Malcom | Chief Medical Offi… | SELL | $500K+ | 20K | $27.93 | Feb 14, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $100K–$500K | 14K | $7.28 | Feb 14, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $15K–$50K | 2K | $16.00 | Feb 11, 2026 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $50K–$100K | 2K | $30.21 | Feb 11, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 416 | $15.44 | Jan 21, 2026 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $1K–$15K | 416 | $32.10 | Jan 21, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $50K–$100K | 8K | $12.39 | Jan 16, 2026 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $500K+ | 19K | $32.66 | Jan 16, 2026 |
| Congleton Jon | CEO | SELL | $500K+ | 16K | $32.62 | Jan 14, 2026 |
| Levy Adam Scott | CFO and Secretary | SELL | $100K–$500K | 11K | $32.14 | Jan 14, 2026 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 9K | $32.56 | Jan 14, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $15K–$50K | 9K | $4.88 | Jan 14, 2026 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $1M+ | 263K | $35.25 | Jan 7, 2026 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1M+ | 253K | $12.27 | Jan 7, 2026 |
| Slingsby Brian Taylor | Director | SELL | $1M+ | 1.0M | $43.35 | Nov 21, 2025 |
| Levy Adam Scott | CFO and Secretary | SELL | $1M+ | 120K | $44.88 | Nov 14, 2025 |
| Levy Adam Scott | CFO and Secretary | EXERCISE | $1M+ | 106K | $14.11 | Nov 14, 2025 |
| Congleton Jon | CEO | SELL | $1M+ | 200K | $45.44 | Nov 14, 2025 |
| Karydas Daphne | Director | EXERCISE | $100K–$500K | 15K | $10.20 | Nov 14, 2025 |
| Karydas Daphne | Director | SELL | $500K+ | 15K | $45.99 | Nov 14, 2025 |
| Gold Alexander M | Director | SELL | $1M+ | 35K | $45.45 | Nov 14, 2025 |
| Gold Alexander M | Director | EXERCISE | $100K–$500K | 35K | $10.92 | Nov 14, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 11K | $36.00 | Sep 16, 2025 |
| AKKARAJU SRINIVAS | Director | BUY | $1M+ | 588K | $25.50 | Sep 9, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 1.2M | $25.50 | Sep 8, 2025 |
| Levy Adam Scott | CFO and Secretary | SELL | $1M+ | 74K | $14.62 | Jul 31, 2025 |
| Congleton Jon | CEO | SELL | $100K–$500K | 16K | $14.51 | Jul 15, 2025 |
| Levy Adam Scott | CFO and Secretary | SELL | $100K–$500K | 11K | $14.45 | Jul 15, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 11K | $14.59 | Jul 15, 2025 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 6K | $1.08 | Jul 15, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 11K | $14.60 | Jun 16, 2025 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 6K | $1.08 | Jun 16, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 11K | $15.29 | May 15, 2025 |
| Slingsby Brian Taylor | Director | BUY | $1M+ | 259K | $13.50 | Apr 25, 2025 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 6K | $1.08 | Apr 16, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 11K | $14.53 | Apr 16, 2025 |
| Levy Adam Scott | CFO and Secretary | SELL | $100K–$500K | 11K | $12.06 | Apr 16, 2025 |
| Congleton Jon | CEO | SELL | $100K–$500K | 15K | $12.19 | Apr 16, 2025 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 2K | $1.08 | Apr 3, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $500K+ | 56K | $15.76 | Apr 3, 2025 |
| Samsara BioCapital GP, LLC | 10% Owner | BUY | $1M+ | 600K | $13.50 | Mar 18, 2025 |
| AKKARAJU SRINIVAS | Director | BUY | $1M+ | 600K | $13.50 | Mar 18, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 1.3M | $13.50 | Mar 17, 2025 |
| Levy Adam Scott | CFO and Secretary | SELL | $50K–$100K | 11K | $9.10 | Jan 16, 2025 |
| Congleton Jon | CEO | SELL | $100K–$500K | 18K | $9.06 | Jan 16, 2025 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $50K–$100K | 5K | $15.00 | Nov 12, 2024 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $1K–$15K | 10K | $0.81 | Nov 12, 2024 |
| Rodman David Malcom | Chief Medical Offi… | EXERCISE | $15K–$50K | 25K | $1.08 | Nov 8, 2024 |
| Rodman David Malcom | Chief Medical Offi… | SELL | $100K–$500K | 25K | $15.03 | Nov 8, 2024 |
| Levy Adam Scott | CFO and Secretary | SELL | $100K–$500K | 11K | $13.57 | Oct 15, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 167 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Catalys Pacific, LLC | 7.9M | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 7.3M | $1M+ | SH |
| Samsara BioCapital, LLC | 5.9M | $1M+ | SH |
| STATE STREET CORP | 3.2M | $1M+ | SH |
| Caligan Partners LP | 2.8M | $1M+ | SH |
| Laurion Capital Management LP | 1.7M | $1M+ | SH |
| Andera Partners | 1.6M | $1M+ | SH |
| SR ONE CAPITAL MANAGEMENT, LP | 1.6M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 1.3M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.2M | $1M+ | SH |
| Capital International Investors | 1.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 980K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 923K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 908K | $1M+ | SH |
| Pictet Asset Management Holding SA | 853K | $1M+ | SH |
| Affinity Asset Advisors, LLC | 730K | $1M+ | SH |
| Siren, L.L.C. | 700K | $1M+ | SH |
| Candriam S.C.A. | 678K | $1M+ | SH |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 659K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
10.1%
8.0M shares
SC 13G · Feb 5, 2026
6.3%
5.0M shares
SC 13G · Jan 21, 2026
5.2%
4.1M shares
SC 13D/A · Sep 9, 2025
7.3%
5.7M shares
SC 13D/A · Sep 8, 2025
9.9%
7.8M shares
SC 13G/A · Aug 14, 2025
4.2%
2.8M shares
SC 13G/A · Aug 14, 2025
13.5%
9.0M shares
SC 13D/A · Mar 18, 2025
9.0%
5.7M shares
SC 13D/A · Mar 17, 2025
9.9%
6.3M shares
SC 13G/A · Feb 14, 2025
2.3%
1.1M shares
SC 13G/A · Nov 13, 2024
5.0%
2.5M shares
HBM Healthcare Investments (Cayman) Ltd.
SC 13G/A · Nov 13, 2024
4.5%
2.2M shares
SC 13G/A · Nov 13, 2024
17.4%
8.7M shares
SC 13G · Feb 15, 2024
6.4%
3.2M shares
SC 13G · Feb 14, 2024
5.6%
2.3M shares
SC 13G · Feb 13, 2024
22.4%
9.2M shares
HBM Healthcare Investments (Cayman) Ltd.
SC 13G · Feb 13, 2024
5.5%
2.2M shares
SC 13D/A · Feb 12, 2024
10.0%
4.9M shares
SC 13D/A · Feb 12, 2024
10.3%
5.1M shares
SC 13D · Feb 24, 2023
7.8%
3.2M shares
SC 13G · Feb 24, 2023
7.0%
2.9M shares
SC 13D · Feb 24, 2023
11.1%
4.5M shares